Theravance Biopharma Inc
NASDAQ:TBPH
Theravance Biopharma Inc
Revenue
Theravance Biopharma Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theravance Biopharma Inc
NASDAQ:TBPH
|
Revenue
$57.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
76%
|
Theravance Biopharma Inc
Revenue Breakdown
Breakdown by Geography
Theravance Biopharma Inc
Total Revenue:
57.4m
USD
|
United States:
57.2m
USD
|
Europe:
223k
USD
|
Breakdown by Segments
Theravance Biopharma Inc
See Also
What is Theravance Biopharma Inc's Revenue?
Revenue
57.4m
USD
Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Revenue amounts to 57.4m USD.
What is Theravance Biopharma Inc's Revenue growth rate?
Revenue CAGR 10Y
76%
Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Theravance Biopharma Inc have been -7% over the past three years , -1% over the past five years , and 76% over the past ten years .